ANI PHARMACEUTICALS, INC Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
ANI PHARMACEUTICALS, INC (ANIP) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 1.60 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-07
- ANI PHARMACEUTICALS, INC antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 1.60M shares, a 30.43% decline year-over-year.
- ANI PHARMACEUTICALS, INC antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 1.60M shares, a 33.33% decline year-over-year.
- ANI PHARMACEUTICALS, INC antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 1.60M shares, a 40.74% decline year-over-year.
- ANI PHARMACEUTICALS, INC antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 2.30M shares, a 17.86% decline year-over-year.
- ANI PHARMACEUTICALS, INC antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 2.00M shares, a 13.04% decline from fiscal 2024.
- ANI PHARMACEUTICALS, INC antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 2.30M shares, a 4.17% decline from fiscal 2023.
- ANI PHARMACEUTICALS, INC antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 2.40M shares, a 7.69% decline from fiscal 2022.
- ANI PHARMACEUTICALS, INC antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 2.60M shares, a 52.94% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 1.60M shares 10-Q · filed 2026-08-07 | 1.60M shares 10-Q · filed 2026-08-07 | |||||
| 2026-03-31 | 1.60M shares 10-Q · filed 2026-05-08 | ||||||
| 2025-12-31 | 2.00M shares 10-K · filed 2026-02-27 | ||||||
| 2025-09-30 | 1.60M shares 10-Q · filed 2025-11-07 | 2.10M shares 10-Q · filed 2025-11-07 | |||||
| 2025-06-30 | 2.30M shares 10-Q · filed 2026-08-07 | 2.40M shares 10-Q · filed 2026-08-07 | |||||
| 2025-03-31 | 2.40M shares 10-Q · filed 2026-05-08 | ||||||
| 2024-12-31 | 2.30M shares 10-K · filed 2026-02-27 | ||||||
| 2024-09-30 | 2.70M shares 10-Q · filed 2025-11-07 | 2.30M shares 10-Q · filed 2025-11-07 | |||||
| 2024-06-30 | 2.80M shares 10-Q · filed 2025-08-08 | 2.30M shares 10-Q · filed 2025-08-08 | |||||
| 2024-03-31 | 2.30M shares 10-Q · filed 2025-05-09 | ||||||
| 2023-12-31 | 2.40M shares 10-K · filed 2026-02-27 | ||||||
| 2023-09-30 | 2.10M shares 10-Q · filed 2024-11-08 | 2.40M shares 10-Q · filed 2024-11-08 | |||||
| 2023-06-30 | 2.50M shares 10-Q · filed 2024-08-06 | 2.50M shares 10-Q · filed 2024-08-06 | |||||
| 2023-03-31 | 2.60M shares 10-Q · filed 2024-05-10 | ||||||
| 2022-12-31 | 2.60M shares 10-K · filed 2025-02-28 | ||||||
| 2022-09-30 | 2.70M shares 10-Q · filed 2023-11-08 | 2.70M shares 10-Q · filed 2023-11-08 | |||||
| 2022-06-30 | 2.70M shares 10-Q · filed 2022-08-08 | 2.60M shares 10-Q · filed 2022-08-08 | |||||
| 2022-03-31 | 2.50M shares 10-Q · filed 2023-05-08 | ||||||
| 2021-12-31 | 1.70M shares 10-K · filed 2024-02-29 | ||||||
| 2021-09-30 | 1.60M shares 10-Q · filed 2022-11-09 | 1.70M shares 10-Q · filed 2022-11-09 | |||||
| 2021-06-30 | 1.70M shares 10-Q · filed 2022-08-08 | 1.70M shares 10-Q · filed 2022-08-08 | |||||
| 2021-03-31 | 1.70M shares 10-Q · filed 2022-05-10 | ||||||
| 2020-12-31 | 1.30M shares 10-K · filed 2023-03-09 | ||||||
| 2020-09-30 | 1.10M shares 10-Q · filed 2021-11-01 | 1.30M shares 10-Q · filed 2021-11-01 | |||||
| 2020-06-30 | 1.00M shares 10-Q · filed 2021-08-06 | 1.40M shares 10-Q · filed 2021-08-06 | |||||
| 2020-03-31 | 1.80M shares 10-Q · filed 2021-05-07 | ||||||
| 2019-12-31 | 3.00M shares 10-K · filed 2022-03-15 | ||||||
| 2019-09-30 | 2.20M shares 10-Q · filed 2020-11-05 | 2.90M shares 10-Q · filed 2020-11-05 | |||||
| 2019-06-30 | 2.20M shares 10-Q · filed 2020-08-06 | 3.20M shares 10-Q · filed 2020-08-06 | |||||
| 2019-03-31 | 4.10M shares 10-Q · filed 2020-05-07 | ||||||
| 2018-12-31 | 4.40M shares 10-K · filed 2021-03-11 | ||||||
| 2018-09-30 | 4.80M shares 10-Q · filed 2019-11-06 | 4.70M shares 10-Q · filed 2019-11-06 | |||||
| 2018-06-30 | 4.70M shares 10-Q · filed 2019-08-07 | 4.60M shares 10-Q · filed 2019-08-07 | |||||
| 2018-03-31 | 4.60M shares 10-Q · filed 2019-05-09 | ||||||
| 2017-12-31 | 4.80M shares 10-K · filed 2020-02-27 | ||||||
| 2017-09-30 | 4.80M shares 10-Q · filed 2018-11-06 | 4.70M shares 10-Q · filed 2018-11-06 | |||||
| 2017-06-30 | 4.80M shares 10-Q · filed 2017-08-03 | 4.70M shares 10-Q · filed 2018-08-07 | |||||
| 2017-03-31 | 4.60M shares 10-Q · filed 2018-05-08 | ||||||
| 2016-12-31 | 4.50M shares 10-K · filed 2019-02-27 | ||||||
| 2016-09-30 | 4.50M shares 10-Q · filed 2017-11-02 | 4.50M shares 10-Q · filed 2017-11-02 | |||||
| 2016-06-30 | 4.50M shares 10-Q · filed 2017-08-03 | 4.50M shares 10-Q · filed 2017-08-03 | |||||
| 2016-03-31 | 4.50M shares 10-Q · filed 2017-05-04 | ||||||
| 2015-12-31 | 4.50M shares 10-K · filed 2018-02-27 | ||||||
| 2015-09-30 | 4.50M shares 10-Q · filed 2016-11-03 | 4.60M shares 10-Q · filed 2016-11-03 | |||||
| 2015-06-30 | 4.60M shares 10-Q · filed 2016-08-04 | 4.60M shares 10-Q · filed 2016-08-04 | |||||
| 2015-03-31 | 4.60M shares 10-Q · filed 2016-05-05 | ||||||
| 2014-12-31 | 4.70M shares 10-K · filed 2017-03-02 | ||||||
| 2014-09-30 | 700.00K shares 10-Q · filed 2015-11-03 | 700.00K shares 10-Q · filed 2015-11-03 | |||||
| 2014-06-30 | 1.10M shares 10-Q · filed 2015-08-04 | 700.00K shares 10-Q · filed 2015-08-04 | |||||
| 2014-03-31 | 700.00K shares 10-Q · filed 2015-05-05 | ||||||
| 2013-12-31 | 2.70M shares 10-K · filed 2016-02-23 | ||||||
| 2013-09-30 | 900.00K shares 10-Q · filed 2014-11-10 | 909.79K shares 10-Q · filed 2013-11-07 | 3.70M shares 10-Q · filed 2014-11-10 | 498.65K shares 10-Q · filed 2013-11-07 | |||
| 2013-06-30 | 4.40M shares 10-Q · filed 2014-08-07 | 253.42K shares 10-Q · filed 2013-08-09 | 4.60M shares 10-Q · filed 2014-08-07 | 250.65K shares 10-Q · filed 2013-08-09 | |||
| 2013-03-31 | 4.90M shares 10-Q · filed 2014-05-12 | ||||||
| 2012-12-31 | 2.70M shares 10-K · filed 2014-02-28 | ||||||
| 2012-09-30 | 242.25K shares 10-Q · filed 2013-11-07 | 115.35K shares 10-Q · filed 2013-11-07 | |||||
| 2012-06-30 | 80.22K shares 10-Q · filed 2013-08-09 | 51.20K shares 10-Q · filed 2013-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |